From: Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia
| Question | n (%) |
|---|---|
| Total | 29 (100%) |
| What should a new treatment mainly improve? | |
| Quality of life | 17 (59.2%) |
| Less hypoglycemic episodes | 5 (18.2%) |
| no response | 7 (22.2%) |
| For which trial length could you imagine to take a study medication? | |
| two weeks | 2 (9.5%) |
| one month | 4 (19.0%) |
| three months | 3 (14.3%) |
| six months | 6 (28. 5%) |
| nine months | 0 (0%) |
| one year | 5 (23.8%) |
| free text option: one and a half year | 1 (4.7%) |
| no response | 6 (28.5%) |